Skip to main content

Table 4 Adverse drug events reported within the first week of the study.

From: Early variations in plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance

 

AL

AA

No. of children

4 (4.4%)

8 (8.3%)

   Abdominal pain

2 (2.2%)

3 (3.1%)

   Vomiting

0 (0%)

2 (2.1%)

   Weakness

0 (0%)

2 (2.1%)

   Headache

1 (1.1%)

1 (1.0%)

   Skin rash with itching

1 (1.1%)

0 (0%)

  1. AL artemether-lumefanthrine; AA artesunate-amodiaquine